A Study to Investigate the Long-term Safety, Tolerability and Efficacy of Balinatunfib in Participants With Crohn's Disease or Ulcerative Colitis (SPECIFI-IBD-LTS) | MicrobiomeTrials
A Study to Investigate the Long-term Safety, Tolerability and Efficacy of Balinatunfib in Participants With Crohn's Disease or Ulcerative Colitis (SPECIFI-IBD-LTS)
TERMINATEDPHASE2INTERVENTIONAL
Trial Details
Start: 2026-05-19Est. Completion: 2026-09-29
Enrollment target: 7 participants
Locations
Texas Digestive Disease Consultants - Southlake- Site Number : 8400005, Southlake, Texas, United States
Investigational Site Number : 0320001, Buenos Aires, Argentina
Investigational Site Number : 1000001, Gorna Oryahovitsa, Bulgaria
Investigational Site Number : 1520016, Santiago, Reg Metropolitana de Santiago, Chile
Investigational Site Number : 1520010, Santiago, Reg Metropolitana de Santiago, Chile
Investigational Site Number : 1520012, Santiago, Reg Metropolitana de Santiago, Chile
Investigational Site Number : 1560002, Guangzhou, China
Investigational Site Number : 1560032, Shanghai, China
Investigational Site Number : 2030001, Olomouc, Czechia
Investigational Site Number : 3800002, Milan, Milano, Italy
Other microbiome trials you might be interested in